Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Endogenous vascular endothelial growth factor-C expression is associated with decreased drug responsiveness in childhood acute myeloid leukemia.

de Jonge HJ, Weidenaar AC, Ter Elst A, Boezen HM, Scherpen FJ, Bouma-Ter Steege JC, Kaspers GJ, Goemans BF, Creutzig U, Zimmermann M, Kamps WA, de Bont ES.

Clin Cancer Res. 2008 Feb 1;14(3):924-30. doi: 10.1158/1078-0432.CCR-07-1821.

2.

Addition of PTK787/ZK 222584 can lower the dosage of amsacrine to achieve equal amounts of acute myeloid leukemia cell death.

Weidenaar AC, de Jonge HJ, Fidler V, ter Elst A, Meeuwsen-de Boer T, Douwes J, Bouma-ter Steege JC, Hählen K, Kamps WA, de Bont ES.

Anticancer Drugs. 2008 Jan;19(1):45-54.

PMID:
18043129
3.

Anti-angiogenesis therapy can overcome endothelial cell anergy and promote leukocyte-endothelium interactions and infiltration in tumors.

Dirkx AE, oude Egbrink MG, Castermans K, van der Schaft DW, Thijssen VL, Dings RP, Kwee L, Mayo KH, Wagstaff J, Bouma-ter Steege JC, Griffioen AW.

FASEB J. 2006 Apr;20(6):621-30.

PMID:
16581970
4.

Angiogenic profile of breast carcinoma determines leukocyte infiltration.

Bouma-ter Steege JC, Baeten CI, Thijssen VL, Satijn SA, Verhoeven IC, Hillen HF, Wagstaff J, Griffioen AW.

Clin Cancer Res. 2004 Nov 1;10(21):7171-8.

5.

Antiangiogenesis therapy for endometriosis.

Nap AW, Griffioen AW, Dunselman GA, Bouma-Ter Steege JC, Thijssen VL, Evers JL, Groothuis PG.

J Clin Endocrinol Metab. 2004 Mar;89(3):1089-95.

PMID:
15001592
6.

Tumor angiogenesis modulates leukocyte-vessel wall interactions in vivo by reducing endothelial adhesion molecule expression.

Dirkx AE, Oude Egbrink MG, Kuijpers MJ, van der Niet ST, Heijnen VV, Bouma-ter Steege JC, Wagstaff J, Griffioen AW.

Cancer Res. 2003 May 1;63(9):2322-9.

7.

Vascular targeting effect of combretastatin A-4 phosphate dominates the inherent angiogenesis inhibitory activity.

Ahmed B, Van Eijk LI, Bouma-Ter Steege JC, Van Der Schaft DW, Van Esch AM, Joosten-Achjanie SR, Lambin P, Landuyt W, Griffioen AW.

Int J Cancer. 2003 May 20;105(1):20-5.

8.

The designer anti-angiogenic peptide anginex targets tumor endothelial cells and inhibits tumor growth in animal models.

van der Schaft DW, Dings RP, de Lussanet QG, van Eijk LI, Nap AW, Beets-Tan RG, Bouma-Ter Steege JC, Wagstaff J, Mayo KH, Griffioen AW.

FASEB J. 2002 Dec;16(14):1991-3. Epub 2002 Oct 18.

PMID:
12397082
9.

Angiostatic proteins and peptides.

Bouma-ter Steege JC, Mayo KH, Griffioen AW.

Crit Rev Eukaryot Gene Expr. 2001;11(4):319-34. Review.

PMID:
12067070

Supplemental Content

Loading ...
Support Center